TScan Therapeutics Inc. (TCRX)
NASDAQ: TCRX
· Real-Time Price · USD
1.53
0.00 (0.00%)
At close: Jun 17, 2025, 10:30 AM
0.00% (1D)
| Bid | 1.53 |
| Market Cap | 86.87M |
| Revenue (ttm) | 4.42M |
| Net Income (ttm) | -131.48M |
| EPS (ttm) | -1.08 |
| PE Ratio (ttm) | -1.42 |
| Forward PE | -1.32 |
| Analyst | Buy |
| Ask | 1.54 |
| Volume | 59,383 |
| Avg. Volume (20D) | 579,892 |
| Open | 1.50 |
| Previous Close | 1.53 |
| Day's Range | 1.45 - 1.54 |
| 52-Week Range | 1.02 - 7.89 |
| Beta | 0.97 |
About TCRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TCRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TCRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
6 days ago · https://www.defenseworld.net
Squarepoint Ops LLC Makes New $59,000 Investment in TScan Therapeutics, Inc. (NASDAQ:TCRX)Squarepoint Ops LLC purchased a new position in shares of TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) during the fourth quarter, according to the company in its most recent disclosure w...
